Lineage Cell Therapeutics, Inc. Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 06/08/2026 | Mar 2026Filed 12/05/2026 | Sep 2025Filed 06/11/2025 | Jun 2025Filed 06/08/2026 | Mar 2025Filed 12/05/2026 | Sep 2024Filed 06/11/2025 | Jun 2024Filed 12/08/2025 | Mar 2024Filed 13/05/2025 |
|---|---|---|---|---|---|---|---|---|
| $1.1 | $1.7 | $3.7 | $2.8 | $1.5 | $3.8 | $1.4 | $1.4 | |
| $1.5 | −$4.8 | −$30 | −$30 | −$4.1 | −$3 | −$5.8 | −$6.5 | |
| −$0.03 | −$0.03 | −$0.13 | −$0.13 | −$0.02 | −$0.02 | −$0.03 | −$0.04 | |
| 261 | 261 | 229 | 228 | 226 | 189 | 189 | 183 |
Trend